LEADERS FREE II: BioFreedom™ Pivotal Study
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Sponsor: Biosensors Europe SA
Listed as NCT02843633, this NA trial focuses on Acute Coronary Syndrome and High Bleeding Risk and remains ongoing. Sponsored by Biosensors Europe SA, it has been updated 22 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
22 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Apr 2022 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Mar 2021 — Apr 2022 [monthly]
Active Not Recruiting NA
▶ Show 17 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Jul 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Feb 2019 — Jul 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2017 — Oct 2017 [monthly]
Recruiting NA
-
Aug 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jul 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jun 2017 — Jul 2017 [monthly]
Recruiting NA
-
May 2017 — Jun 2017 [monthly]
Recruiting NA
-
Mar 2017 — May 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Mar 2017 [monthly]
Not Yet Recruiting NA
Status: Withheld → Not Yet Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Biosensors Europe SA
For direct contact, visit the study record on ClinicalTrials.gov .